News
-
-
-
PRESS RELEASE
Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth
Zomedica Corp. reports highest quarterly revenue ever and 19th consecutive year-over-year revenue growth, achieving $8.1M in sales. Record Diagnostics and Therapeutic Device segment performance drive success -
PRESS RELEASE
In a landmark industry transaction, Evotec signs agreement with Sandoz, resulting in payments potentially over US$ 650 m plus royalties
Evotec SE signs landmark agreement with Sandoz, leading to over US$650m in payments plus royalties. Deal includes acquisition of manufacturing site and technology license fees -
PRESS RELEASE
Sandoz boosts in-house biosimilars capabilities by signing agreement to acquire Just-Evotec Biologics EU SAS in Toulouse
Sandoz strengthens biosimilars capabilities with acquisition of Just-Evotec Biologics EU SAS in Toulouse. Acquisition aims to capture projected biosimilar market opportunity. Transaction includes cash payment and technology license fees -
-
-
PRESS RELEASE
Augmentation de capital d’un volume augmenté de 70 millions de CHF achevée avec succès
Augmentation de capital de 70 millions de CHF réussie pour Fundamenta Real Estate SA, visant à financer des investissements immobiliers. Annonce événementielle conforme à l'art. 53 du règlement de cotation -
PRESS RELEASE
SMX And CARTIF To Evaluate Potential Collaboration to Accelerate 'Physical-To-Digital' Circular-Economy Innovation Across Spain & Europe
SMX and CARTIF sign non-binding letter of intent to integrate molecular marking technology into sustainability and Industry 5.0 projects. Potential partnership aims to enhance circular economy in Spain and EU -
